Literature DB >> 24982329

Erdheim-Chester disease: a comprehensive review.

Ahmed Maher Abdelfattah1, Karim Arnaout2, Imad A Tabbara3.   

Abstract

Erdheim-Chester disease is a rare form of non-Langerhans' cell histiocytosis characterized by multi-system infiltration by xanthogranulomas composed of foamy histiocytes surrounded by fibrosis. Approximately 400 cases have been reported in the literature, and the recent increase in the number of cases is likely due to the increased awareness of its associated morbidity and mortality. The etiology of this disease remains unknown, the clinical course is variable and treatment is still not well-established. The objective of this review is to describe the pathogenesis, clinical manifestations, and diagnosis of this rare disorder, and to review its prognosis and treatment. Erdheim-Chester disease (ECD) is a rare form of non-Langerhans' cell histiocytosis. It was first described in 1930. Approximately 400 cases have been reported in the literature. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Erdheim-Chester disease; Langerhans' cell histiocytosis; review

Mesh:

Year:  2014        PMID: 24982329

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

Review 1.  [Erdheim-Chester disease and Rosai-Dorfman disease: Pathological, radiological and clinical features of adult non-Langerhans cell histiocytosis].

Authors:  H Bösmüller; D Nann; M Horger; F Fend
Journal:  Pathologe       Date:  2015-09       Impact factor: 1.011

2.  Thoracic involvement in Erdheim-Chester disease: computed tomography imaging findings and their association with the BRAFV600E mutation.

Authors:  S Mojdeh Mirmomen; Arlene Sirajuddin; Moozhan Nikpanah; Rolf Symons; Anna K Paschall; Ioannis Papageorgiou; William A Gahl; Kevin O'Brien; Juvianee I Estrada-Veras; Ashkan A Malayeri
Journal:  Eur Radiol       Date:  2018-05-07       Impact factor: 5.315

3.  Primary non-hyperlipidemia xanthoma of bone: a case report with review of the literature.

Authors:  Zhuo Wang; Zhong-Wei Lin; Lei-Lei Huang; Zun-Fu Ke; Can-Jiao Luo; Wen-Lin Xie; Lian-Tang Wang
Journal:  Int J Clin Exp Med       Date:  2014-11-15

4.  Erdheim-Chester Disease: Two cases from an ophthalmic perspective.

Authors:  James Brodie; Sean Zhou; Damodar Makkuni; Clare Beadsmoore; Chetan Mukhtyar; Janak Saada; Kristian M Bowles; Bijan Beigi; Ben J L Burton
Journal:  Am J Ophthalmol Case Rep       Date:  2020-11-02

5.  Erdheim-Chester Disease: A Case Report.

Authors:  Jean Alexiou; Jean Klastersky
Journal:  Am J Case Rep       Date:  2015-06-11

6.  Erdheim-Chester Disease Presenting with Secondary Hypertension as a Result of Bilateral, Proximal Renal Artery Stenosis: A Case Report.

Authors:  Farid Arman; Hania Shakeri; Niloofar Nobakht; Anjay Rastogi; Mohammad Kamgar
Journal:  Case Rep Nephrol Dial       Date:  2017-05-23

7.  FDA Approval Summary: Vemurafenib for the Treatment of Patients with Erdheim-Chester Disease with the BRAFV600 Mutation.

Authors:  Patricia A Oneal; Virginia Kwitkowski; Lola Luo; Yuan Li Shen; Sriram Subramaniam; Stacy Shord; Kirsten B Goldberg; Amy E McKee; Edvardas Kaminskas; Ann Farrell; Richard Pazdur
Journal:  Oncologist       Date:  2018-08-17

8.  Chinese Erdheim-Chester disease: clinical-pathology-PET/CT updates.

Authors:  Huanyu Ding; Yang Li; Caishun Ruan; Yuan Gao; Hehua Wang; Xiangsong Zhang; Zhihong Liao
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-09-03

9.  Resolved heart tamponade and controlled exophthalmos, facial pain and diabetes insipidus due to Erdheim-Chester disease.

Authors:  Jaume Monmany; Esther Granell; Laura López; Pere Domingo
Journal:  BMJ Case Rep       Date:  2018-10-17

10.  Rare diseases of bone: Erdheim-Chester and Rosai-Dorfman non-Langerhans cell histiocytoses.

Authors:  Andreas F Mavrogenis; Vasilios G Igoumenou; Thekla Antoniadou; Panayiotis D Megaloikonomos; George Agrogiannis; Periklis Foukas; Sotirios G Papageorgiou
Journal:  EFORT Open Rev       Date:  2018-06-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.